New Report - Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) By MarketsandM

DALLAS, August 18, 2010 /PRNewswire/ -- According to the new market research report "Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)", published by MarketsandMarkets (http://www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion due to rising demand from U.S. and Europe.

Browse in-depth TOC on Bioinformatics Market.

Early buyers will receive 10% customization of reports

http://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

Bioinformatics has gained high importance due to its ability to facilitate rapid clinical research, and also due to its various applications such as gene therapy and molecular science. Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality, as the current competitive scenario offers little scope for price escalation and product differentiation.

The market for bioinformatics platforms is growing at a significant pace with the increasing demand from U.S. and Europe. This trend is supported by the increasing demand for sequencing platforms with increasing life science research using techniques such as gene expression analysis, sequence analysis, and protein expression analysis.

The global bioinformatics market is expected to reach $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion, due to rising demand from the U.S. and Europe.

Markets covered

This research report categorizes the global bioinformatics market into the following segments:

    - Bioinformatics platforms
    - Sequence alignment platforms
    - Sequence manipulation platforms,
    - Sequence analysis platforms
    - Structural analysis platforms
    - Content/Knowledge management tools
    - Specialized knowledge management tools
    - Generalized knowledge management tools
    - Services
    - Data Analysis
    - Sequencing Services
    - Database & Management services
    - Applications

    What makes our reports unique?

    - We provide the longest market segmentation chain in this
    industry- not many reports provide market breakdown upto level 5.

    - We provide 10% customization. Normally it is seen that clients do
    not find specific market intelligence that they are looking for. Our
    customization will ensure that you necessarily get the market
    intelligence you are looking for and we get a loyal customer.

    - 15 pages of high level analysis including benchmarking
    strategies, best practices and the market's cash cows (BCG matrix). We
    conduct detailed market positioning, product positioning and competitive
    positioning. Entry strategies, gaps and opportunities are identified for
    all the stakeholders.

Powerful Research and Analysis

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website http://www.marketsandmarkets.com

    Contact:
    Ms. Sunita
    7557 Rambler Road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    Email: [email protected]
    http://marketsandmarkets.wordpress.com/
    http://marketsandmarkets.blogspot.com/

SOURCE MarketsandMarkets

Suggested Articles

Solid Bio fixed the manufacturing issue that led to a partial clinical hold on its DMD trial, but a full hold remains.

Commissioner Scott Gottlieb has laid out the reasons why he thinks the FDA needs a double-digit budget bump.

GW's cannabis-based epilepsy drug scored a favorable review from FDA staff ahead of an expert panel meeting.